Furthermore, our co-IP experiments also show that the Lapatinib induces FOXO3 acetylation and that inhibition of SIRT2 by chemical inhibitor or silencing also promotes FOXO3 acetylation in NPC cells. This evidence concerns the gene FOXO3 and nasopharyngeal carcinoma.